Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

CVS Health reported strong first-quarter results that exceeded Wall Street’s expectations. The company’s revenue ...

Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

The company now expects to achieve revenues between $150 millionand $170 million for 2025 compared with the previous guidance of ... growth rate of 11.4%. CVS’s earnings surpassed estimates ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.

Investing.com -- Lundbeck (CSE: HLUNb) on Wednesday raised its full-year revenue and earnings guidance after reporting a 16% increase in first-quarter revenue at constant exchange rates to DKK 6.24 ...

The operating environment has been challenging for the company due to decreasing sales worldwide and the effects of U.S.

The Wall Street veteran's technical analysis of natural gas helped members capture gains on UNG calls. His recent alert ...

The company posted adjusted earnings per share of ... Based on the robust Q1 results, Exelixis raised its full-year 2025 revenue guidance to $2.25-$2.35 billion, up from its previous forecast ...